Structure/Function of Terminal Complement Proteins

末端补体蛋白的结构/功能

• 批准号: 6748098
• 负责人: JAMES M SODETZ
• 金额: $ 27.21万
• 依托单位: UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
• 依托单位国家: 美国
• 财政年份: 1989
• 资助国家: 美国
• 起止时间: 1989-09-01 至 2007-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6748098
• 关键词: X ray crystallography; bacteriolysis; binding sites; chemical binding; chimeric proteins; complement; eicosanoids; fatty acids; gene mutation; laboratory rabbit; ligands; membrane lipids; molecular cloning; prostaglandins; protein binding; protein structure function; recombinant proteins; site directed mutagenesis

DESCRIPTION (provided by applicant): The long-term objective of this project is to understand molecular details of the formation and function of human C5b-9, the cytolytic complex of complement referred to as the "membrane attack complex" or MAC. MAC is composed of C5b, C6, C7, C8 and C9. Among these components, C6, C7, the C8alpha and C8beta subunits, and C9 are homologous whereas C8gamma has the distinction of being the only lipocalin in the complement system. This project will focus on C8 as a model system to identify structure-function relationships within the MAC proteins. Emphasis will be on C8gamma and the possibility it has a previously unrecognized role in MAC formation and function. Specific aims are: (1) to characterize the ligand binding properties of C8gamma. The C8gamma crystal structure displays a typical lipocalin fold with a distinct binding site for an as yet unidentified small molecule. Studies will focus on fatty acids and related compounds as potential ligands to determine if C8gamma has the capacity to bind membrane lipid, e.g. glycerophospholipids and LPS, or possibly soluble proinflammatory molecules released in the vicinity of the MAC; (2) to test the hypothesis that C8gamma enhances MAC activity through direct interaction with membrane-associated lipid. Mutants in which ligand binding is restricted will be prepared and characterized with respect to retention/loss of ability to enhance MAC hemolytic and bactericidal activities. Positive results would suggest C8gamma may be involved in inducing MAC-mediated responses in nucleated cells; (3) to identify functionally important binding sites in C8. The site on C8gamma that binds C8alpha will be identified using chimeric constructs of C8gamma and its structural homologue NGAL, and testing these for C8alpha binding. The region of C8beta which binds the intermediate MAC complex C5b-7 will use C8alpha / C8beta chimeras and C8beta deletion mutants to determine the role of the modules; (4) to produce fragments of the MAC proteins for crystallization and structural studies. Segments of C8alpha and C8beta will be produced recombinantly and by proteolytic digestion of serum-derived C8. The former approach will emphasize the central MACPF segment because it is likely to be self-folding domain that can be expressed. The latter approach will take advantage of scale. When complete, results will provide new insight into mechanisms by which the MAC proteins interact with each other and the target cell membrane. Such information will facilitate design and development of therapeutically useful analogues of MAC and regulators of MAC lytic and stimulatory functions. Because of the uniqueness of the MAC proteins and their function, information obtained will contribute to an understanding of protein structure-function relationships in general.

描述（由申请人提供）：该项目的长期目标是了解人类 C5b-9 的形成和功能的分子细节，C5b-9 是补体的溶细胞复合物，称为“膜攻击复合物”或 MAC。 MAC由C5b、C6、C7、C8和C9组成。在这些成分中，C6、C7、C8α 和 C8β 亚基以及 C9 是同源的，而 C8gamma 的区别在于它是补体系统中唯一的脂质运载蛋白。该项目将重点关注 C8 作为模型系统来识别 MAC 蛋白内的结构-功能关系。重点将放在 C8gamma 上，以及它在 MAC 形成和功能中具有先前未被认识到的作用的可能性。具体目标是：(1)表征C8gamma的配体结合特性。 C8gamma 晶体结构显示出典型的脂质运载蛋白折叠，具有针对尚未鉴定的小分子的独特结合位点。研究将集中于脂肪酸和相关化合物作为潜在配体，以确定 C8gamma 是否具有结合膜脂的能力，例如甘油磷脂和 LPS，或可能在 MAC 附近释放的可溶性促炎分子； (2) 检验 C8gamma 通过与膜相关脂质直接相互作用增强 MAC 活性的假设。将制备配体结合受到限制的突变体，并表征其增强MAC溶血和杀菌活性的能力的保留/丧失。阳性结果表明 C8gamma 可能参与诱导有核细胞中 MAC 介导的反应； (3) 鉴定C8中功能重要的结合位点。将使用 C8gamma 及其结构同源物 NGAL 的嵌合构建体来鉴定 C8gamma 上结合 C8alpha 的位点，并测试它们的 C8alpha 结合。 C8beta与中间MAC复合物C5b-7结合的区域将使用C8alpha/C8beta嵌合体和C8beta缺失突变体来确定模块的作用； (4)产生MAC蛋白片段用于结晶和结构研究。 C8α 和 C8β 片段将通过重组并通过血清来源的 C8 的蛋白水解消化来产生。前一种方法将强调中心 MACPF 段，因为它很可能是可以表达的自折叠域。后一种方法将利用规模优势。完成后，结果将为 MAC 蛋白彼此之间以及与靶细胞膜相互作用的机制提供新的见解。这些信息将有助于设计和开发治疗上有用的 MAC 类似物以及 MAC 溶解和刺激功能的调节剂。由于 MAC 蛋白及其功能的独特性，所获得的信息将有助于总体上理解蛋白质结构-功能关系。